113
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma

ORCID Icon, , , ORCID Icon &
Pages 4677-4690 | Published online: 23 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sawkar Vijay Pramod, Ferry Safriadi, Bethy S Hernowo, Reiva Farah Dwiyana, Nurvita Trianasari & Shin Egawa. (2023) Cytoplasmic Androgen Receptor, CD24 Expression and Smoking Intensity to Urothelial Carcinoma of the Bladder Invasiveness: A Cross-Sectional Study. Research and Reports in Urology 15, pages 485-494.
Read now
Zhongjie Qiao, Hongshuang Dai, Yunzhu Zhang, Qiang Li, Meng Zhao & Tongyun Yue. (2020) LncRNA NCK1-AS1 Promotes Cancer Cell Proliferation and Increase Cell Stemness in Urinary Bladder Cancer Patients by Downregulating miR-143. Cancer Management and Research 12, pages 1661-1668.
Read now

Articles from other publishers (16)

Yawen Wang, Haoran Yu, Mengyuan Yu, Hui Liu, Bing Zhang, Yuanyuan Wang, Simin Zhao & Qingxin Xia. (2023) CD24 blockade as a novel strategy for cancer treatment. International Immunopharmacology 121, pages 110557.
Crossref
Haruka Matsukuma, Yuka Kobayashi, Shintaro Oka, Fumiaki Higashijima, Kazuhiro Kimura, Erika Yoshihara, Noriaki Sasai & Koji Shiraishi. (2023) Prominin‐1 deletion results in spermatogenic impairment, sperm morphological defects, and infertility in mice . Reproductive Medicine and Biology 22:1.
Crossref
Di Chen, Zhihua Luo, Chaoping Ye, Quanhai Luo, Wenji Fan, Changsheng Chen & Gang Liu. (2022) Constructing and validating nomograms to predict risk and prognostic factors of distant metastasis in urothelial bladder cancer patients: a population-based retrospective study. BMC Urology 22:1.
Crossref
Amina Fouad Farag & Nadia Fathy Hassabou. (2022) CD24-gold nanocomposite as promising and sensitive biomarker for cancer stem cells in salivary gland tumors. Nanomedicine: Nanotechnology, Biology and Medicine 46, pages 102598.
Crossref
Liming Jin, Zhaoxia Zhang, Zhang Wang, Xiaojun Tan, Zhaoying Wang, Lianju Shen, Chunlan Long, Guanghui Wei & Dawei He. (2022) Novel piRNA MW557525 regulates the growth of Piwil2-iCSCs and maintains their stem cell pluripotency. Molecular Biology Reports 49:7, pages 6957-6969.
Crossref
Ruizhi Geng, Niklas Harland, Ivonne A. Montes-Mojarro, Falko Fend, Wilhelm K. Aicher, Arnulf Stenzl & Bastian Amend. (2022) CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?. International Journal of Molecular Sciences 23:10, pages 5453.
Crossref
L. I. Belyakova, A. N. Shevchenko, A. B. Sagakyants, E. S. Bondarenko, O. G. Shulgina, E. P. Ulyanova,, E. V. Filatova & I. A. Khomutenko. (2022) The number of cancer stem cells in the tumor tissue and perifocal tissue of non-muscle invasive bladder cancer. South Russian Journal of Cancer 3:1, pages 6-14.
Crossref
Margaretha A. Skowron, Teresa K. Becker, Lukas Kurz, Sina Jostes, Felix Bremmer, Florian Fronhoffs, Kai Funke, Gamal A. Wakileh, Melanie R. Müller, Aaron Burmeister, Thomas Lenz, Anja Stefanski, Kai Stühler, Patrick Petzsch, Karl Köhrer, Peter Altevogt, Peter Albers, Glen Kristiansen, Hubert Schorle & Daniel Nettersheim. (2021) The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas. Molecular Oncology 16:4, pages 982-1008.
Crossref
F.I. Grabovenko, O.V. Kisil, G.V. Pavlova & M.E. Zvereva. (2022) Protein CD133 as a tumor stem cell marker. Voprosy neirokhirurgii imeni N.N. Burdenko 86:6, pages 113.
Crossref
Shiran Shapira, Gal Aiger, Amitay Ohayon, Dina Kazanov, Fatin Mdah, Marina Ben Shimon, Mori Hay-Levy, Lian Banon, Ido Laskov, Jacob Mashiah, Shahar Lev-Ari & Nadir Arber. (2021) Predictors of the CD24/CD11b Biomarker among Healthy Subjects. Journal of Personalized Medicine 11:9, pages 939.
Crossref
Jaromir Hacek, Antonin Brisuda, Marek Babjuk & Josef Zamecnik. (2021) Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesions. Biomedical Papers 165:3, pages 316-321.
Crossref
Damian Kołat, Żaneta Kałuzińska, Andrzej K. Bednarek & Elżbieta Płuciennik. (2021) WWOX Loses the Ability to Regulate Oncogenic AP-2γ and Synergizes with Tumor Suppressor AP-2α in High-Grade Bladder Cancer. Cancers 13:12, pages 2957.
Crossref
Damian Kołat, Żaneta Kałuzińska, Andrzej K. Bednarek & Elżbieta Płuciennik. (2021) Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer. Frontiers in Oncology 11.
Crossref
Valentina Pasquale, Giacomo Ducci, Gloria Campioni, Adria Ventrici, Chiara Assalini, Stefano Busti, Marco Vanoni, Riccardo Vago & Elena Sacco. (2020) Profiling and Targeting of Energy and Redox Metabolism in Grade 2 Bladder Cancer Cells with Different Invasiveness Properties. Cells 9:12, pages 2669.
Crossref
Wenju Mo, Yuqin Ding, Shuai Zhao, Dehong Zou & Xiaowen Ding. (2020) Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis. PLOS ONE 15:11, pages e0241924.
Crossref
Yang-Hong Ni, Xia Zhao & Wei Wang. (2020) CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy. Current Gene Therapy 20:2, pages 109-126.
Crossref